Williams Cancer Institute (@WmsCInstitute) header
Williams Cancer Institute (@WmsCInstitute) profile picture

The World Leaders in Cancer Care, changing the way cancer is treated.

Joined July 2025
Photo by Williams Cancer Institute (@WmsCInstitute)Photo by Williams Cancer Institute (@WmsCInstitute)Photo by Williams Cancer Institute (@WmsCInstitute)Photo by Williams Cancer Institute (@WmsCInstitute)Photo by Williams Cancer Institute (@WmsCInstitute)Photo by Williams Cancer Institute (@WmsCInstitute)Photo by Williams Cancer Institute (@WmsCInstitute)Photo by Williams Cancer Institute (@WmsCInstitute)Photo by Williams Cancer Institute (@WmsCInstitute)Photo by Williams Cancer Institute (@WmsCInstitute)
E-cigarettes cut exposure to many of the cancer-causing chemicals in cigarette smoke while still delivering nicotine. Experimental studies show nicotine can help tumor cells survive, multiply and grow the blood vessels that feed them. Nicotine is not a classic carcinogen, though researchers think it may help cancers progress. For anyone with a history of cancer, switching to vaping lowers some risks and leaves the nicotine risk in place. Our blog post on e-cigarettes is at williamscancerinstitute.com/…
5
1
31
5,597
Williams Cancer Institute treats advanced prostate cancer with techniques it has been refining since 2008. The treatment is designed for prostate cancer that has outlasted hormone therapy and other treatments. Because prostate tumors tend to keep immune cells out, we inject several immune drugs directly into the tumor after cryoablation or pulsed electric field ablation. We coordinate with your oncology and urology teams. You can request a free evaluation for advanced prostate cancer at williamscancerinstitute.com/…
4
1
34
6,039
Tune in to our livestream today at 1PM PST / 4PM EST with @jasonwilliamsmd and @drgoodyear to hear more on the relationship between chemotherapy and aging.
Chemotherapy can save a breast cancer patient's life and may still take years off of it. A modeling study published in @JAMANetworkOpen estimates that survivors treated with anthracycline chemotherapy lose a median of 9.4 years of life to accelerated biological aging. The doctors break down the study this Friday on Beyond the Standard. Watch live on X and our other channels
4
3
36
6,342
Chemotherapy can save a breast cancer patient's life and may still take years off of it. A modeling study published in @JAMANetworkOpen estimates that survivors treated with anthracycline chemotherapy lose a median of 9.4 years of life to accelerated biological aging. The doctors break down the study this Friday on Beyond the Standard. Watch live on X and our other channels
5
2
1
42
6,468
Antibiotics taken within 60 days of starting checkpoint immunotherapy are consistently linked to poorer outcomes, according to a meta-analysis cited by Elkrief and colleagues in 2025. Antibiotics can wipe out the gut bacteria that help the immune system respond to treatment. If you are about to start immunotherapy, tell your oncologist about any antibiotics you have taken in the last two months.
8
4
62
6,917
Stage IV lung cancer patients treated with pulsed electric field ablation had 74.3% one-year survival, compared with 33% in a control group, in a 41-patient study from NYU, Weill Cornell and Duke. All 41 had already received immunotherapy, chemotherapy or both without benefit. The study was small and retrospective, and its authors describe it as limited. Williams Cancer Institute uses pulsed electric field ablation for lung cancer, paired with immunotherapy injected into the tumor. Lung cancer patients can request a free evaluation at williamscancerinstitute.com/…
4
6
1
73
7,920
We will be live today at 1PM PT with this rescheduled livestream topic - can diet & fasting fight cancer? Learn more here on X.
Can diet and fasting fight cancer? @jasonwilliamsmd and @drgoodyear weigh in this Friday on Beyond the Standard, starting from a recent review of fasting and metabolic diets in oncology. The episode also covers the FDA's approval of dostarlimab, the immunotherapy that let most patients in its rectal cancer trial avoid surgery, chemo, and radiation. Watch live on X and our other channels.
4
3
38
5,828
Colorectal cancer patients who drank at least two cups of coffee a day had a lower risk of the cancer coming back, in a Dutch study of 1,719 people. Death rates were lowest at three to five cups a day, with no added benefit above five. The study, published in the International Journal of Cancer, found an association and cannot prove coffee prevents recurrence. The full article on coffee and colorectal cancer is at williamscancerinstitute.com/…
4
14
1
60
6,801
Williams Cancer Institute treats lung cancer with techniques it has been refining since 2008. We treat lung cancer that cannot be operated on, has spread, or has stopped responding to treatment. We use pulsed electric field ablation to destroy the tumor and then inject immunotherapy into it. The National Comprehensive Cancer Network's guidelines already include ablation for stage I non-small cell lung cancer in patients who cannot have surgery. To ask whether your lung cancer case is a fit, request a free evaluation at williamscancerinstitute.com/…
5
11
1
43
5,870
Even light drinking was linked to more prostate cancer in a European Journal of Cancer study of 82,570 Finnish men published this year. Light drinkers had about an 18% higher rate than non-drinkers, moderate drinkers a 20% higher rate and heavy drinkers a 32% higher rate. The study cannot prove alcohol causes prostate cancer, but the rate rose with every level of drinking. The full article on alcohol and prostate cancer is at williamscancerinstitute.com/…
4
2
51
6,489
Williams Cancer Institute treats liver cancer with techniques it has been refining since 2008. We treat both primary liver cancer and cancers that have spread to the liver from other organs. Because the liver has its own artery, we can deliver immunotherapy through that artery and concentrate the drug where the tumors are. Most patients complete treatment in about a week. Liver cancer patients can book a free evaluation at williamscancerinstitute.com/…
4
2
54
9,271
We will be postponing this livestream to next week as a result of some scheduling conflicts. Doctors are busy people!
Can diet and fasting fight cancer? @jasonwilliamsmd and @drgoodyear weigh in this Friday on Beyond the Standard, starting from a recent review of fasting and metabolic diets in oncology. The episode also covers the FDA's approval of dostarlimab, the immunotherapy that let most patients in its rectal cancer trial avoid surgery, chemo, and radiation. Watch live on X and our other channels.
4
4
7
48
6,599
Can diet and fasting fight cancer? @jasonwilliamsmd and @drgoodyear weigh in this Friday on Beyond the Standard, starting from a recent review of fasting and metabolic diets in oncology. The episode also covers the FDA's approval of dostarlimab, the immunotherapy that let most patients in its rectal cancer trial avoid surgery, chemo, and radiation. Watch live on X and our other channels.
4
23
1
82
10,501
Shortness of breath during immunotherapy needs a doctor's attention right away, because it can signal pneumonitis, an inflammation of the lungs. Pneumonitis and pneumonia can look alike on a scan. Fever and a high white blood cell count point more toward pneumonia than pneumonitis. Doctors usually need a CT scan to diagnose pneumonitis, because a chest X-ray can miss it. Our blog post on immunotherapy side effects is at williamscancerinstitute.com/…
4
7
44
6,401
About 5 to 10% of breast cancers are linked to a gene mutation inherited from a parent. Many families with a strong history of breast cancer carry changes in genes other than BRCA1 and BRCA2, such as PALB2, CHEK2 and ATM. Doctors classify a variant as high risk when it carries a lifetime breast cancer risk above 50%. Inheriting a high-risk variant raises the odds of breast cancer without making it certain. Our blog post on inherited breast cancer is at williamscancerinstitute.com/…
4
38
8,928
A biopsy that tests low for PD-L1 can miss PD-L1 elsewhere in the tumor. The edges of a tumor, where immune cells meet cancer cells, often show more PD-L1 than the center. Tumors can also release PD-L1 into the blood inside tiny particles called exosomes, beyond the reach of a tissue test. Because many insurers decide immunotherapy coverage on biomarker results, an incomplete test can cost a patient access to treatment. Our blog post on tumor biomarkers is at williamscancerinstitute.com/…
4
40
8,952